Author

DONNAH M. JONES

Observed names: D Jones, D. M. Jones, Donnah Jones, Donnah M. Jones

Observed institutions: United States Food and Drug Administration, The University of Texas MD Anderson Cancer Center, Columbus Community Clinical Oncology Program, The Ohio State University

OpenAlex ID: A5102192012

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

1993 · R Kurzrock, J Redman, et al. · PubMed · 168

Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer

2004 · Paul Mathew, Peter F. Thall, et al. · Journal of Clinical Oncology · 127

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases

2007 · Paul Mathew, Peter F. Thall, et al. · Clinical Cancer Research · 89

Combination Chemotherapy for Metastatic or Locally Advanced Genitourinary Squamous Cell Carcinoma: a Phase Ii Study of Methotrexate, Cisplatin and Bleomycin

1998 · DAVID A. CORRAL, AVISHAY SELLA, et al. · The Journal of Urology · 86

Phase II Study of Dolastatin-10 as First-Line Treatment for Advanced Colorectal Cancer

2002 · Everardo D. Saad, Eric H. Kraut, et al. · American Journal of Clinical Oncology · 64

Phase I Study of Concurrent Weekly Docetaxel and Repeated Samarium-153 Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer

2009 · Shi-Ming Tu, Paul Mathew, et al. · Journal of Clinical Oncology · 53

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

2000 · Lance Pagliaro, Danai Daliani, et al. · Cancer · 50

Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer

2003 · Randall Millikan, Peter F. Thall, et al. · Journal of Clinical Oncology · 41

Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer

1996 · Shi-Ming Tu, Ebrahim S. Delpassand, et al. · Urologic Oncology Seminars and Original Investigations · 37

Characterization of the anaplastic prostate carcinomas: A prospective two-stage phase II trial of frontline carboplatin and docetaxel (CD) and salvage etoposide and cisplatin (EP).

2011 · A. Aparicio, A. L. Harzstark, et al. · Journal of Clinical Oncology · 3

Combination Chemotherapy for Metastatic or Locally Advanced Genitourinary Squamous Cell Carcinoma

1998 · DAVID A. CORRAL, AVISHAY SELLA, et al. · The Journal of Urology

Works count: 11

Citation count: 718

H-index: 9

I10-index: 9